
Venture capital firm led by a technology investor with two decades of experience in North Carolina
Angel investor group funding seed-stage life science and healthcare companies in the Boston area

Investing at the seed stage, and only in life science and healthcare, is the business of Mass Medical Angels, also called MA2. The group backs and coaches early companies, helping them reach a next round, positive cash flow or an acquisition. Its stated mission is to bring more clinical tools to the marketplace while earning returns for its investors.
The group says its members are carefully vetted for their deep expertise in the health sciences. Many have worked as researchers, clinicians, venture capitalists, executives, consultants, engineers, bankers or attorneys, and they bring a willingness to support early companies. The group draws on relationships with institutions in the Boston healthcare supercluster, which it describes as a major healthcare innovation hub. Those institutions supply deal flow, expertise and advisers for the companies the group works with.
The group provides early-stage funding in a set range and can supply all or part of a round, depending on the size of the investment. It says it is willing to work closely with other angel groups or venture funds so that a round closes and the company is adequately capitalized.
The group looks for companies that are extremely capital efficient and where its funding can lead to significant step-ups in valuation, partly to avoid unfavorable later funding rounds. It states a target return of five times the investment within five years.
The group's fields include therapeutics, medical devices, diagnostics, health services, health IT, and research tools such as laboratory equipment. Companies can submit a business plan through its website to be considered.
Mass Medical Angels, also called MA2, is a seed-stage investor group focused only on life science and healthcare. It funds and mentors young companies so they can raise further money, reach positive cash flow or be acquired.
Early-stage companies in medical devices, therapeutics, diagnostics, health services, health information technology and research tools such as laboratory equipment. It prefers capital-efficient companies.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Mass Medical Angels.
Similar listings buyers compare against this one.

Venture capital firm led by a technology investor with two decades of experience in North Carolina
New York venture capital firm making early and growth stage investments on the East Coast, mostly as co-investor

Seed-stage venture investor backing founders in technology, healthcare and other sectors

Venture platform investing in early-stage technology companies where sport, media and consumer culture meet

A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

Pharmaceutical group's partnering and venture investment arm working with outside biotech innovators

Venture capital firm backing early-stage technology companies in the US and Israel

Spanish venture capital manager investing in early-stage biotech, medtech and digital health start-ups
Everything here links back to the same verified catalogue. Pick your next stop.